FONAR (FONR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
26 Feb, 2026Executive summary
A special committee of independent directors negotiated a merger for the company to go private, resulting in a cash acquisition by an entity controlled by key executives and directors, at $19.00 per share for Common and Class B stock, $6.34 for Class C, and $10.50 for Class A Non-voting Preferred Stock, representing significant premiums to recent trading prices.
The merger is structured as a “going private” transaction, with the company becoming a wholly owned subsidiary of the acquirer, and its shares delisted from Nasdaq.
The transaction is subject to approval by both a majority of all voting shares and a majority of votes cast by disinterested stockholders, with additional litigation requiring a potential supermajority vote under Delaware law.
The merger consideration was deemed fair by an independent financial advisor, Marshall & Stevens, whose analysis included discounted cash flow, market, and liquidation scenarios.
If the merger is not completed, the company will remain public, and no payments will be made to stockholders.
Voting matters and shareholder proposals
Stockholders are asked to vote on the merger agreement and a proposal to adjourn the meeting if more votes are needed.
Approval requires both a majority of all voting shares and a majority of disinterested stockholder votes; a pending lawsuit may require a two-thirds supermajority of unaffiliated shares.
Voting agreements have been signed by the acquisition group, representing over 40% of voting power, but their votes are excluded from the disinterested stockholder approval.
Appraisal rights are available for stockholders who do not vote in favor and follow statutory procedures.
Board of directors and corporate governance
The special committee, composed of two independent directors, led negotiations, retained independent legal and financial advisors, and received fixed, non-contingent fees for their service.
Interested directors recused themselves from deliberations and voting on the merger.
After the merger, the board will consist solely of the acquirer’s designee, and the company will be privately controlled.
Latest events from FONAR
- Six-month net income fell 16%, but quarterly net income rose 15%; merger at $19/share signed.FONR
Q2 202617 Feb 2026 - Definitive merger agreement signed for $19.00/share; quarterly net income up 15% year-over-year.FONR
Proxy Filing17 Feb 2026 - Management-led buyout at $19/share offers 31.5% premium, pending shareholder approval.FONR
Proxy Filing30 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditors amid continued growth and strong liquidity.FONR
Proxy Filing2 Dec 2025 - Revenue up 4% to $26M, but net income down 33% as costs rise and uncertainty persists.FONR
Q1 202614 Nov 2025 - Revenue up 1%, net income down 24%, with record scan volumes and expansion plans.FONR
Q4 202525 Sep 2025 - Net income rose 16% on record scan volumes and continued expansion of MRI centers.FONR
Q4 202413 Jun 2025 - MRI scan volume rose, but revenue and net income declined amid higher costs and disruptions.FONR
Q1 202513 Jun 2025 - Q3 net income up 24%, but nine-month profit fell as costs and scan volumes rose.FONR
Q3 20256 Jun 2025